Chloe joined British Patient Capital in September 2021 from Legal & General, a FTSE 100 asset manager, where she was an early-stage venture investor. Her tenure at Legal & General was segmented into health tech investing and a secondment to ADV, a generalist seed-stage fund manager. Prior to this, she was a transactions advisor for growth-stage deep-tech companies.